Industry Partnerships & Commercialization
The Industry Partnerships and Commercialization (IP&C) Office at The Hospital for Sick Children (SickKids) champions the identification, development, and commercialization of cutting-edge health innovations from SickKids researchers, partnering with industry and investors to translate these innovations into impactful healthcare services and products worldwide.
Transforming SickKids Innovation into Global Health Impact
At IP&C, our team comprises individuals with deep scientific expertise and extensive experience in patenting, licensing, commercial transactions, and startup ventures.
We go beyond traditional tech transfer roles by assisting SickKids Innovators in de-risking their discoveries, maximizing their value, and aligning with investor interests.
Discover how we connect ideas, industry, and investors to create efficient commercialization pathways at SickKids!
Latest News
Novel therapeutic compositions for degrading bacterial and fungal biofilms P. Lynne Howell, PhD Senior Scientist | Molecular Medicine Technology 1-Pager Lab Website [...]
SickKids Ranked One of Canada's Top 40 Research Hospitals for 2021 SickKids has once again been named one of Canada’s top research hospitals by Research Infosource. [...]
Pfizer Completes Acquisition of Trillium Therapeutics On November 17, 2021, Pfizer Inc. announced the successful completion of its acquisition of Trillium Therapeutics, a clinical stage immuno-oncology [...]
SickKids scientist Dr. Jean-Philippe Julien named one of Canada's Top 40 Under 40 Congratulations to Dr. Jean-Philippe Julien, one of our entrepreneurial scientists at The Hospital for Sick [...]
